Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study
This was a small, phase 1 open-label study of 10 adult females with anorexia nervosa or partial remission who each received a single 25 mg dose of synthetic psilocybin plus psychological support. The main goal was to check safety and whether the treatment was tolerable and feasible. No serious adverse…